Harvard Bioscience Gross Profit 2010-2023 | HBIO

Harvard Bioscience gross profit from 2010 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Harvard Bioscience Annual Gross Profit
(Millions of US $)
2023 $66
2022 $61
2021 $68
2020 $58
2019 $64
2018 $63
2017 $39
2016 $48
2015 $49
2014 $49
2013 $48
2012 $52
2011 $50
2010 $52
2009 $42
Harvard Bioscience Quarterly Gross Profit
(Millions of US $)
2023-12-31 $16
2023-09-30 $15
2023-06-30 $17
2023-03-31 $18
2022-12-31 $16
2022-09-30 $12
2022-06-30 $17
2022-03-31 $16
2021-12-31 $20
2021-09-30 $16
2021-06-30 $16
2021-03-31 $15
2020-12-31 $18
2020-09-30 $13
2020-06-30 $14
2020-03-31 $13
2019-12-31 $17
2019-09-30 $15
2019-06-30 $16
2019-03-31 $16
2018-12-31 $19
2018-09-30 $16
2018-06-30 $15
2018-03-31 $13
2017-12-31 $11
2017-09-30 $10
2017-06-30 $9
2017-03-31 $10
2016-12-31 $12
2016-09-30 $12
2016-06-30 $12
2016-03-31 $13
2015-12-31 $13
2015-09-30 $12
2015-06-30 $13
2015-03-31 $11
2014-12-31 $14
2014-09-30 $11
2014-06-30 $12
2014-03-31 $12
2013-12-31 $12
2013-09-30 $11
2013-06-30 $12
2013-03-31 $12
2012-12-31 $13
2012-09-30 $12
2012-06-30 $14
2012-03-31 $13
2011-12-31 $13
2011-09-30 $12
2011-06-30 $13
2011-03-31 $12
2010-12-31 $14
2010-09-30 $13
2010-06-30 $12
2010-03-31 $13
2009-12-31 $13
2009-09-30 $10
2009-06-30 $9
2009-03-31 $9
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.157B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $26.480B 32.51
Bruker (BRKR) United States $11.768B 31.38
Kewaunee Scientific (KEQU) United States $0.099B 11.71